SCHEMBL7330870

SCHEMBL7330870

Cc1c(C(=O)N2CC(C)NC(C)C2)c2cc(Cl)ccc2n2cnc(C(=O)OC(C)(C)C)c12

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.51
GABRG2 P18507 1/20 0.51
GABRB3 P28472 1/20 0.51
GABRA5 P31644 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7330862 1.00 GABRA1 (0.51) GABRA1GABRG2GABRB3GABRA5
SCHEMBL7328808 0.90 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRA5
SCHEMBL7328800 0.90 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRA5
SCHEMBL8602404 0.88 PAK4 (0.42) GABRA1GABRG2GABRB3GABRA5
SCHEMBL8602399 0.88 PAK4 (0.42) GABRA1GABRG2GABRB3GABRA5
SCHEMBL7334074 0.88 GABRA1 (0.37) GABRA1GABRG2GABRB3GABRA5
SCHEMBL7334082 0.88 GABRA1 (0.37) GABRA1GABRG2GABRB3GABRA5
SCHEMBL7362181 0.84 GABRA1 (0.52) GABRA1GABRG2GABRB3GABRA5
SCHEMBL7328859 0.84 GABRA1 (0.52) GABRA1GABRG2GABRB3GABRA5
SCHEMBL7329687 0.84 GABRA1 (0.52) GABRA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729469-B1 IMIDAZO [1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS UPJOHN CO (US) 1998-09-23 EP claimed
US-5594140-A Imidazo[1,5-A]quinolines for treatment of anxiety and sleep disorders THE UPJOHN COMPANY (US) 1997-01-14 US claimed
EP-0729469-A1 IMIDAZO [1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-09-04 EP claimed
WO-1995014020-A1 IMIDAZO[1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS THE UPJOHN COMPANY (US) 1995-05-26 WO claimed